| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.16 | 0.004 |